A Study to Evaluate Ethanol-induced Symptoms and Safety in Breast Cancer Patients

Boryung

Status: Enrolling

Conditions: Breast Cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT06537752

BR-DTX-OS-402

Details and patient eligibility

About

The purpose of this study is to evaluate ethanol-induced symptoms and safety in breast cancer patients with neoadjuvant/adjuvant chemotherapy including Non-ethanol formulation docetaxel before and after surgery

Enrollment: 1,052 estimated patients

Sex: Female

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Those who voluntarily signed a written personal information collection and usage agreement after receiving an explanation about the objective and method, etc. of this clinical study.

• Those are confirmed to have primary breast cancers through histological diagnosis and one of the following are applicable.

  • Those who need neoadjuvant chemotherapy as breast cancer patients
  • Those who need adjuvant chemotherapy after breast cancer surgery

• Those who are scheduled to administer non-ethanol formulation docetaxel according to chemotherapy

• Those able to understand this study, be cooperative in the execution of the study, and participate in the study until its completion.

Exclusion criteria

• Those are diagnosed with other primary cancer that can influence the treatment or prognosis of primary breast cancers.
• Those are diagnosed with secondary breast cancers.
• Those with Stage 0/1 (Tis, N0, M0) or Stage IV (any T, Any N, M1) breast cancers.